TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Argent Biopharma ( (AU:RGT) ) has issued an announcement.
Argent Biopharma Limited announced the issuance of 3,300,000 convertible notes and 21,950,952 unlisted options exercisable at A$0.1025, expiring on December 3, 2028. This move is part of a previously announced transaction and reflects the company’s strategic efforts to strengthen its financial position and enhance its market operations.
More about Argent Biopharma
Argent Biopharma Limited operates in the biotechnology industry, focusing on the development and commercialization of pharmaceutical products.
Average Trading Volume: 87,148
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$5.91M
See more insights into RGT stock on TipRanks’ Stock Analysis page.